Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ILLUMINA, INC.ILMN · Entity 3137 | SVP, Entrepreneurial Devlopmt | December 10, 2020 | December 14, 2020 |
| Seer, Inc.SEER · Entity 6717 | Director | June 14, 2023 | June 17, 2023 |
| Senti Biosciences Holdings, Inc.DYNS · Entity 7935 | Director · Chief Executive Officer | May 25, 2021 | May 26, 2021 |
| Summit Therapeutics Inc.SMMT · Entity 3477 | Director | January 02, 2026 | January 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ILLUMINA, INC.
Report date December 10, 2020 · Filed December 14, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 80,162 |
Ending reported balance
After 2020-12-10 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2020-12-10 · Sale · Disposed 1,300 · Balance 83,862 F1: The sale was made pursuant to a 10b5-1 plan. F2: Weighted average sale price representing 1,300 shares sold ranging from $336.2100 to $337.0850 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Row 2 · 2020-12-10 · Sale · Disposed 1,100 · Balance 82,762 F1: The sale was made pursuant to a 10b5-1 plan. F3: Weighted average sale price representing 1,100 shares sold ranging from $337.8000 to $338.4450 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Row 3 · 2020-12-10 · Sale · Disposed 2,200 · Balance 80,562 F1: The sale was made pursuant to a 10b5-1 plan. F4: Weighted average sale price representing 2,200 shares sold ranging from $339.1100 to $339.9900 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Row 4 · 2020-12-10 · Sale · Disposed 400 · Balance 80,162 F1: The sale was made pursuant to a 10b5-1 plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale was made pursuant to a 10b5-1 plan.
F2: Weighted average sale price representing 1,300 shares sold ranging from $336.2100 to $337.0850 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
F3: Weighted average sale price representing 1,100 shares sold ranging from $337.8000 to $338.4450 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
F4: Weighted average sale price representing 2,200 shares sold ranging from $339.1100 to $339.9900 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Seer, Inc.
Report date June 14, 2023 · Filed June 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 224,903 |
Reported balance
After 2023-06-14 transaction · row 1
1 source rowRow 1 · 2023-06-14 · Grant · Acquired 23,443 · Balance 224,903 F1: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.33 · Expires 2033-06-14 | Direct | 34,735 |
Reported balance
After 2023-06-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-06-14 · Grant · Acquired 34,735 · Balance 34,735 F6: Shares subject to the option vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 15,157 |
Reported balance
Holding disclosure · report date 2023-06-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15,157 F2: The shares are held of record Phi-X Capital, LLC, for which the reporting person serves as a manager. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 76,722 |
Reported balance
Holding disclosure · report date 2023-06-14 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 76,722 F3: The shares are held of record by First Republic Trust Company of Delaware LLC, trustee of a dynasty trust for the reporting person's minor daughter and for which the reporting person serves as an investment advisor. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 76,722 |
Reported balance
Holding disclosure · report date 2023-06-14 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 76,722 F4: The shares are held of record by First Republic Trust Company of Delaware LLC, trustee of a dynasty trust for the reporting person's minor son and for which the reporting person serves as an investment advisor. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 76,722 |
Reported balance
Holding disclosure · report date 2023-06-14 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 76,722 F5: The shares are held of record by The Ronaghi Children's Trust UTD December 2014 for which the reporting person serves as a trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders.
F2: The shares are held of record Phi-X Capital, LLC, for which the reporting person serves as a manager.
F3: The shares are held of record by First Republic Trust Company of Delaware LLC, trustee of a dynasty trust for the reporting person's minor daughter and for which the reporting person serves as an investment advisor.
F4: The shares are held of record by First Republic Trust Company of Delaware LLC, trustee of a dynasty trust for the reporting person's minor son and for which the reporting person serves as an investment advisor.
F5: The shares are held of record by The Ronaghi Children's Trust UTD December 2014 for which the reporting person serves as a trustee.
F6: Shares subject to the option vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders.
Senti Biosciences Holdings, Inc.
Report date May 25, 2021 · Filed May 26, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | IndirectSee footnote | 715,500 |
Reported balance
Holding disclosure · report date 2021-05-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 715,500 F1: Up to 60,000 of these shares of Class A common stock will be forfeited in the event the underwriters for the Issuer's initial public offering do not exercise in full their overallotment option in connection with that offering, all as described in the Issuer's prospectus on Form S-1 filed on May 7, 2021 (the "Prospectus"). F2: Dynamics Sponsor LLC, a Delaware limited liability company, (the "Sponsor") is the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. |
| Class B common stockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectSee footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2021-05-25 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F3: These shares of Class B common stock will automatically convert on a one-for-one basis (subject to adjustment) into Class A common stock for no additional consideration at the time of the initial business combination by the Issuer, subject to the adjustments described in the Prospectus. The shares of Class B Common Stock have no expiration date. F4: Up to 750,000 of these shares of Class B common stock will be forfeited in the event the underwriters for the Issuer's initial public offering do not exercise in full their overallotment option in connection with that offering, all as described in the Prospectus. F2: Dynamics Sponsor LLC, a Delaware limited liability company, (the "Sponsor") is the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Up to 60,000 of these shares of Class A common stock will be forfeited in the event the underwriters for the Issuer's initial public offering do not exercise in full their overallotment option in connection with that offering, all as described in the Issuer's prospectus on Form S-1 filed on May 7, 2021 (the "Prospectus").
F2: Dynamics Sponsor LLC, a Delaware limited liability company, (the "Sponsor") is the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein.
F3: These shares of Class B common stock will automatically convert on a one-for-one basis (subject to adjustment) into Class A common stock for no additional consideration at the time of the initial business combination by the Issuer, subject to the adjustments described in the Prospectus. The shares of Class B Common Stock have no expiration date.
F4: Up to 750,000 of these shares of Class B common stock will be forfeited in the event the underwriters for the Issuer's initial public offering do not exercise in full their overallotment option in connection with that offering, all as described in the Prospectus.
Summit Therapeutics Inc.
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.52 · Expires 2036-01-02 | Direct | 35,000 |
Reported balance
After 2026-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 35,000 · Balance 35,000 F2: Not applicable. F1: The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date.
F2: Not applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2026 Filed Jan 6, 2026 18:44 UTC | Summit Therapeutics Inc. SMMT · Entity 3477 | GrantStock Option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $17.52 | Not disclosed |
DisclosureSEC source: 0001441876-26-000002 · wk-form4_1767743091.xml · derivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2036-01-02 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 19:11 UTC | Summit Therapeutics Inc. SMMT · Entity 3477 | GrantStock Option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $18.35 | Not disclosed |
DisclosureSEC source: 0001599298-25-000025 · wk-form4_1736208674.xml · derivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2035-01-02 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 09:21 UTC | Summit Therapeutics Inc. SMMT · Entity 3477 | GrantStock Option (right to buy) · Derivative | 25,315 | Not disclosed Strike: $4.03 | Not disclosed |
DisclosureSEC source: 0001599298-24-000070 · wk-form4_1713187295.xml · derivative · entry 2 Ronaghi Mostafa · CIK 0001441876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,315 Underlying: Common Stock · 25,315 shares Expires 2034-04-11 F2 · price: Not applicable. F3 · derivative.exercise_date: The option was granted on April 11, 2024 and represents a pro rata amount of the annual 35,000 option board grant based approximately on the number of days the reporting person is anticipated to serve as a director in 2024. The shares underlying the option are scheduled to vest in full on December 31, 2024, subject to the director remaining as a non-salaried director on such vesting date. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 09:21 UTC | Summit Therapeutics Inc. SMMT · Entity 3477 | GrantStock Option (right to buy) · Derivative | 200,000 | Not disclosed Strike: $4.03 | Not disclosed |
DisclosureSEC source: 0001599298-24-000070 · wk-form4_1713187295.xml · derivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2034-04-11 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on April 11, 2024. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on April 11, 2025, subject to the director remaining as a non-salaried director on each such vesting date. Read SEC document |
| June 14, 2023 Filed Jun 17, 2023 01:20 UTC | Seer, Inc. SEER · Entity 6717 | GrantStock Option (right to buy) · Derivative | 34,735 | $0.00 Strike: $4.33 | $0.00 |
DisclosureSEC source: 0001209191-23-038200 · doc4.xml · derivative · entry 6 Ronaghi Mostafa · CIK 0001441876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,735 Underlying: Class A Common Stock · 34,735 shares Expires 2033-06-14 F6 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 14, 2023 Filed Jun 17, 2023 01:20 UTC | Seer, Inc. SEER · Entity 6717 | GrantClass A Common Stock | 23,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038200 · doc4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,903 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:54 UTC | Seer, Inc. SEER · Entity 6717 | GrantStock Option (right to buy) · Derivative | 29,640 | $0.00 Strike: $7.33 | $0.00 |
DisclosureSEC source: 0001209191-22-038131 · doc4.xml · derivative · entry 6 Ronaghi Mostafa · CIK 0001441876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,640 Underlying: Class A Common Stock · 29,640 shares Expires 2031-06-15 F6 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 15, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:54 UTC | Seer, Inc. SEER · Entity 6717 | GrantClass A Common Stock | 9,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038131 · doc4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,460 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 15, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:14 UTC | Seer, Inc. SEER · Entity 6717 | GrantStock Option (right to buy) · Derivative | 27,939 | $0.00 Strike: $64.48 | $0.00 |
DisclosureSEC source: 0001209191-21-012220 · doc4.xml · derivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,939 Underlying: Class A Common Stock · 27,939 shares Expires 2031-02-16 F1 · derivative.exercise_date: Shares subject to the option vest in 36 equal monthly installments beginning on March 16, 2021. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 21:12 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 400 | $341.00 | $136,400.00 |
DisclosureSEC source: 0001127602-20-031257 · form4.xml · nonDerivative · entry 4 Ronaghi Mostafa · CIK 0001441876 · SVP, Entrepreneurial Devlopmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,162 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 21:12 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 2,200 | $339.42 | $746,729.06 |
DisclosureSEC source: 0001127602-20-031257 · form4.xml · nonDerivative · entry 3 Ronaghi Mostafa · CIK 0001441876 · SVP, Entrepreneurial Devlopmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,562 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 2,200 shares sold ranging from $339.1100 to $339.9900 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 21:12 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,100 | $337.99 | $371,790.87 |
DisclosureSEC source: 0001127602-20-031257 · form4.xml · nonDerivative · entry 2 Ronaghi Mostafa · CIK 0001441876 · SVP, Entrepreneurial Devlopmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,762 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 1,100 shares sold ranging from $337.8000 to $338.4450 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 21:12 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,300 | $336.92 | $438,002.11 |
DisclosureSEC source: 0001127602-20-031257 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP, Entrepreneurial Devlopmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,862 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 1,300 shares sold ranging from $336.2100 to $337.0850 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 22:43 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 1,171 | $311.72 | $365,024.12 |
DisclosureSEC source: 0001127602-20-028502 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP, Entrepreneurial Devlopmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,162 F1 · balance_after: Balance includes 19 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 21:49 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 192 | $393.04 | $75,463.68 |
DisclosureSEC source: 0001127602-20-022240 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP, Entrepreneurial Devlopmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,314 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:08 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionPerformance Shares · Derivative | 11,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005389 · form4.xml · derivative · entry 4 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,728 shares Expires 2019-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:08 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 8,226 | $296.00 | $2,434,896.00 |
DisclosureSEC source: 0001127602-20-005389 · form4.xml · nonDerivative · entry 3 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,506 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:08 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 11,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005389 · form4.xml · nonDerivative · entry 2 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:08 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 5,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005389 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,004 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 150% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantPerformance Shares · Derivative | 4,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004411 · form4.xml · derivative · entry 2 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,995 Underlying: Common Stock · 4,995 shares Expires 2023-01-01 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004411 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,140 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 5, 2021, February 5, 2022, February 5, 2023 and February 5, 2024, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 68 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 21:43 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 1,178 | $300.87 | $354,424.86 |
DisclosureSEC source: 0001127602-19-032203 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,407 Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:46 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $69.34 | $0.00 |
DisclosureSEC source: 0001127602-19-030734 · form4.xml · derivative · entry 6 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2021-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:46 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 100 | $312.87 | $31,287.00 |
DisclosureSEC source: 0001127602-19-030734 · form4.xml · nonDerivative · entry 5 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,585 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:46 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,394 | $311.86 | $434,738.56 |
DisclosureSEC source: 0001127602-19-030734 · form4.xml · nonDerivative · entry 4 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,685 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 1,394 shares sold ranging from $311.43 to $312.42 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:46 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,296 | $310.74 | $402,723.19 |
DisclosureSEC source: 0001127602-19-030734 · form4.xml · nonDerivative · entry 3 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,079 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 1,296 shares sold ranging from $310.43 to $311.09 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:46 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,210 | $309.89 | $374,961.94 |
DisclosureSEC source: 0001127602-19-030734 · form4.xml · nonDerivative · entry 2 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,375 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 1,210 shares sold ranging from $309.15 to $310.14 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:46 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 4,000 | $69.34 | $277,360.00 |
DisclosureSEC source: 0001127602-19-030734 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 21:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $69.34 | $0.00 |
DisclosureSEC source: 0001127602-19-028752 · form4.xml · derivative · entry 6 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 10,000 shares Expires 2021-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 21:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 803 | $301.72 | $242,280.92 |
DisclosureSEC source: 0001127602-19-028752 · form4.xml · nonDerivative · entry 5 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,585 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 803 shares sold ranging from $301.44 to $302.14 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 21:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 4,664 | $300.89 | $1,403,364.95 |
DisclosureSEC source: 0001127602-19-028752 · form4.xml · nonDerivative · entry 4 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,388 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 4,664 shares sold ranging from $300.44 to $301.39 per share. Number of shares sold at each separateprice will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 21:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 4,133 | $300.12 | $1,240,379.01 |
DisclosureSEC source: 0001127602-19-028752 · form4.xml · nonDerivative · entry 3 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,052 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 4,133 shares sold ranging from $299.41 to $300.40 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 21:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 400 | $298.25 | $119,298.00 |
DisclosureSEC source: 0001127602-19-028752 · form4.xml · nonDerivative · entry 2 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,185 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 400 shares sold ranging from $298.13 to $298.42 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 21:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 10,000 | $69.34 | $693,400.00 |
DisclosureSEC source: 0001127602-19-028752 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:50 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $69.34 | $0.00 |
DisclosureSEC source: 0001127602-19-026980 · form4.xml · derivative · entry 4 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 10,000 shares Expires 2021-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:50 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,800 | $286.37 | $515,457.72 |
DisclosureSEC source: 0001127602-19-026980 · form4.xml · nonDerivative · entry 3 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,585 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 1,800 shares sold ranging from $286.15 to $286.66 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:50 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 8,200 | $285.33 | $2,339,745.36 |
DisclosureSEC source: 0001127602-19-026980 · form4.xml · nonDerivative · entry 2 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,385 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 8,200 shares sold ranging from $285.00 to $285.93 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:50 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 10,000 | $69.34 | $693,400.00 |
DisclosureSEC source: 0001127602-19-026980 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:44 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 191 | $304.41 | $58,142.31 |
DisclosureSEC source: 0001127602-19-025540 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,585 Read SEC document |
| July 15, 2019 Filed Jul 18, 2019 15:38 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $69.34 | $0.00 |
DisclosureSEC source: 0001127602-19-024838 · form4.xml · derivative · entry 7 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 10,000 shares Expires 2021-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| July 15, 2019 Filed Jul 18, 2019 15:38 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 500 | $305.40 | $152,698.00 |
DisclosureSEC source: 0001127602-19-024838 · form4.xml · nonDerivative · entry 6 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,776 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 500 shares sold ranging from $305.02 to $305.92 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| July 15, 2019 Filed Jul 18, 2019 15:38 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 300 | $304.14 | $91,242.00 |
DisclosureSEC source: 0001127602-19-024838 · form4.xml · nonDerivative · entry 5 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,276 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 300 shares sold ranging from $303.80 to $304.31 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| July 15, 2019 Filed Jul 18, 2019 15:38 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 767 | $302.95 | $232,364.18 |
DisclosureSEC source: 0001127602-19-024838 · form4.xml · nonDerivative · entry 4 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,576 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 767 shares sold ranging from $302.62 to $303.50 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| July 15, 2019 Filed Jul 18, 2019 15:38 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 5,716 | $301.93 | $1,725,843.88 |
DisclosureSEC source: 0001127602-19-024838 · form4.xml · nonDerivative · entry 3 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,343 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 5,716 shares sold ranging from $301.60 to $302.53 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| July 15, 2019 Filed Jul 18, 2019 15:38 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 2,717 | $301.16 | $818,244.11 |
DisclosureSEC source: 0001127602-19-024838 · form4.xml · nonDerivative · entry 2 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,059 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 2,717 shares sold ranging from $300.59 to $301.56 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| July 15, 2019 Filed Jul 18, 2019 15:38 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 10,000 | $69.34 | $693,400.00 |
DisclosureSEC source: 0001127602-19-024838 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 23:07 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $69.34 | $0.00 |
DisclosureSEC source: 0001127602-19-022310 · form4.xml · derivative · entry 11 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 Underlying: Common Stock · 10,000 shares Expires 2021-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 23:07 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 299 | $352.39 | $105,364.37 |
DisclosureSEC source: 0001127602-19-022310 · form4.xml · nonDerivative · entry 10 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,776 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F8 · price: Weighted average sale price representing 299 shares sold ranging from $352.19 to $352.63 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. F9 · balance_after: Balance reflects an increase of 154 shares. The previous balance was incorrect due to an administrative error. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 23:07 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,281 | $351.30 | $450,011.71 |
DisclosureSEC source: 0001127602-19-022310 · form4.xml · nonDerivative · entry 9 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,075 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F7 · price: Weighted average sale price representing 1,281 shares sold ranging from $351.05 to $352.03 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 23:07 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 2,964 | $350.62 | $1,039,250.72 |
DisclosureSEC source: 0001127602-19-022310 · form4.xml · nonDerivative · entry 8 Ronaghi Mostafa · CIK 0001441876 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,356 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 2,964 shares sold ranging from $350.05 to $351.04 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.